|
UNITED STATES
For more information, please contact:
- Joyce Wedemeyer | E-mail Address: Joyce.Wedemeyer@pharmaforceintl.com Send E-mail
SUBSCRIPTIONS
A powerful web-based program that allows clients to access up-to-date information on the leading pharmaceutical sales forces throughout the United States
AVAILABLE SYNDICATED STUDIES
This benchmarking program offers unparalleled in-depth analysis of the sales and marketing activities supporting key oncology brands throughout the United States
This study includes side-by-side comparisons of the unique commercial operations approaches of leading organizations in the United States
-
Ophthalmology Sales and Marketing Franchises in the United States
[2024]
This study includes side-by-side comparisons of the unique commercial operations approaches of leading organizations in the United States
-
Central Nervous System Sales and Marketing Franchises in the United States
[2024]
This report benchmarks the key commercial operations of top companies promoting products indicated for schizophrenia, multiple sclerosis, bipolar, MDD, and Alzheimer’s
This study benchmarks key pharmaceutical companies’ strategic approaches to market access and reimbursement functions in the United States
This study includes side-by-side comparisons of the unique commercial operations approaches of leading organizations in the United States
This benchmarking program describes in detail each leading pharmaceutical company’s strategy for leveraging medical liaisons and similar personnel
-
Digital Marketing Approaches and Expenditures Benchmarking
[2022]
This report benchmarks the select Digital Marketing Approaches and Expenditures of key Oncology and Immunology organizations
-
Multiple Sclerosis Sales and Marketing Franchises in the United States
[2021]
[2018]
[2016]
This comprehensive study includes side-by-side comparisons of commercial operations for the top multiple sclerosis franchises
-
Parkinson’s and Alzheimer’s Diseases Sales and Marketing Franchises in the United States
[2021]
This benchmarking project helps you understand how various target organizations structure their Parkinson’s and Alzheimer’s diseases sales and marketing operations in the United States.
This benchmarking project helps you understand how various target organizations structure their Migraine sales and marketing operations in the United States.
A strategically relevant and timely report to help understand operational challenges during the pandemic and share insights on how companies are adapting to the unprecedented situation.
This interactive tool provides an opportunity to sort and compare historical to current Sales FTE data, as well as FTEs by indication of leading Oncology organizations in the United States
-
Benchmarking of Leading HIV/HCV/HBV Sales and Marketing Organizations
[2019]
This benchmarking project helps you understand how various target organizations structure their virology sales and marketing operations in the United States.
-
Biosimilars: Strategic Overview of Current Market Entries and Anticipated Near-Term Approvals
[2019]
[2017]
This unique report draws on analysis of biosimilars trends across the United States over the past year, observations of the differing practices undertaken by new entrants, and other insights identified during the research process.
-
Competitive Benchmarking of Leading Hemophilia Sales and Marketing Organizations
[2017]
The report profiles existing players as well as new entrants in Hemophilia therapeutic area throughout the United States. Both Hemophilia A and Hemophilia B products will be profiled in the report along with a focus on smaller, more complex commercial teams
-
Managed Markets: Strategies of Leading Pharma Companies
[2017]
[2016]
This benchmarking program describes in detail each leading pharmaceutical company’s strategic approach to managed markets
STILL DIDN'T FIND WHAT YOU ARE LOOKING FOR?
|